RESEARCH-USE BIOSIMILAR ANTIBODY
Labetuzumab
Monoclonal antibody · IgG1
Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy.
TARGETCEA
YMonoclonal antibody
CATALOGSC-BS-453
CATALOG NUMBERSC-BS-453
MOLECULAR WEIGHTApprox. 145.48 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy.
Labetuzumab is a recombinant research-use antibody directed against CEA.